Free CME from PeerView


Oncology CME

PVI, PeerView Institute for Medical Education
RCC Clinical Consults: Making Difficult Treatment Decisions at the Intersection of the Data and the Real World
November 03, 2022
PVI, PeerView Institute for Medical Education
Clinical Conundrums in Pretreated Metastatic Urothelial Carcinoma: Improving Patient Outcomes With Novel Antibody-Drug Conjugates
October 26, 2022
PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
October 23, 2022
PVI, PeerView Institute for Medical Education
The Eye-Deal Connection in Multiple Myeloma: Establishing Ophthalmology-Oncology Relationships to Overcome Ocular Toxicity
September 30, 2022
PVI, PeerView Institute for Medical Education
Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings
September 29, 2022
PVI, PeerView Institute for Medical Education
Extending Survival and Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right
September 29, 2022
PVI, PeerView Institute for Medical Education
An "Off-the-Shelf" Approach for Myeloma Care: Visualizing the Present and Future of BCMA Antibodies
September 29, 2022
Medical Learning Institute, Inc.
The Power of Personalized Medicine in AML: Linking Individualized Treatment to Enhanced Patient Outcomes
September 28, 2022
Medical Learning Institute, Inc.
Challenges and Changes With Targeted Options in CLL: Guidance on Making Evidence-Informed Upfront and Sequential Treatment Choices
September 28, 2022
Medical Learning Institute, Inc.
The “Innovation Moment” Arrives for MDS: Guidance on Building Personalized Management Plans to Improve Patient Outcomes
September 26, 2022
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
September 25, 2022
PVI, PeerView Institute for Medical Education
Refining Biomarker Testing and Targeted Treatment of NSCLC With Common and Uncommon EGFR Mutations
September 24, 2022
PVI, PeerView Institute for Medical Education
Moving Beyond Conventional Care for DLBCL: Oncology Nurse Leadership for the Effective and Safe Use of Innovative Antibody and Cellular Therapies
September 13, 2022
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
September 01, 2022
PVI, PeerView Institute for Medical Education
Rebooting the BTK Inhibitor Sequence in MCL: Team-Centered Guidance on the Personalized Selection of Covalent and Noncovalent BTK Inhibitors in Relapsed/Refractory Disease
September 01, 2022
PVI, PeerView Institute for Medical Education
Reaching the Next Level of Myeloma Patient Care: Oncology Nurse Guidance on Antibody Therapy and Novel Mechanisms of Action
August 10, 2022
Medical Learning Institute, Inc.
Building Real-World Bridges Between Clinicians and Patients With Myeloma: Guidance on Innovative Antibody Options
July 26, 2022
PVI, PeerView Institute for Medical Education
Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies: New Evidence on the Individualized Use of BTK Inhibitors in Relapsed/Refractory CLL/SLL and MCL
July 14, 2022
Medical Learning Institute, Inc.
New Rules for BTK Inhibitors in CLL: Benchmarks for Evidence-Based Treatment Selection, Sequencing, and Safety Management
July 14, 2022

Pages